Arrowhead Pharmaceuticals Inc stock is traded at $57.46, with a volume of 1,806,674. It is down -6.80% in the last 24 hours and down -7.84% over the past month. Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
Previous Close:
$61.65
Open:
$61.65
24h Volume:
1,806,674
Relative Volume:
1.32
Market Cap:
$8.12B
Revenue:
$622.01M
Net Income/Loss:
-$271.86M
P/E Ratio:
-
EPS:
-$2.15
Net Cash Flow:
-$45.87M
1W Performance:
-5.01%
1M Performance:
-7.84%
6M Performance:
-23.32%
1Y Performance:
+42.55%
1-Day Range:
$57.24$61.73
1-Week Range:
$57.24$62.00
52-Week Range:
$37.06$95.49
Arrowhead Pharmaceuticals Inc Stock (ARWR) Company Profile
Name
Arrowhead Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
626-696-4702Address
177 E COLORADO BLVD, PASADENA, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS